ASSESSMENT OF OCRELIZUMAB (OCR) TREATMENT EFFECTS ON FUNCTIONAL IMPAIRMENT OF MS PATIENTS ENROLLED IN THE PHASE III ORCHESTRA PROGRAMME USING MULTIMODAL EVOKED POTENTIALS (EP) AND HIGHRESOLUTION ELECTROENCEPHALOGRAPHY (EEG):